Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NovoCure (N2VC34.SA) Q4 2025 Earnings
N2VC34.SA
30
Oct
Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-3.56
-2.96
-2.36
-1.76
Details
Expected EPS
-2.258755434
Actual EPS
-1.77606
Surprise EPS
0.48
Surprise Percent
+21.37%
Description
NovoCure (N2VC34.SA) has reported earnings of -1.77606 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login